Metastatic Non-small Cell Lung Cancer Clinical Trials
3 recruiting trials for Metastatic Non-small Cell Lung Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT07222566
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants...
This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with...
Sponsor: PfizerEnrolling: 141017 locations
RECRUITINGNCT05985330
Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1...
Based on the use of the patient's natural defences, immunotherapy mobilizes the immune system to recognize and destroy cancer cells, and it has revolutionized the treatment of...
Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 561 location
RECRUITINGPhase 1 / Phase 2NCT06975293
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers
This early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and antitumor activity of STC-15 (a METTL3 inhibitor) in...
Sponsor: STORM Therapeutics LTDEnrolling: 1883 locations